← FDA Drug Approvals (Drugs@FDA)

MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA · Approved 2007-03-07

Drug application

FDA Application #
ANDA076980
Application type
Abbreviated New Drug Application (Generic)
Brand name
MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
Generic name
Hydrochlorothiazide
Active ingredients
HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE
Dosage form
TABLET
Route
ORAL
Marketing status
Prescription
Sponsor
TEVA
First approval
2007-03-07

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown